India to start Covid vaccination drive from January 16: Check details

Indian drug regulator has granted the emergency use authorisation or accelerated approval for two vaccines

Coronavirus, vaccine, covid, drugs, clinical trials
Representational image of a Covid-19 vaccine
BS Reporter
2 min read Last Updated : Jan 09 2021 | 5:17 PM IST
India will start the Covid vaccination drive on January 16 after the forthcoming festivals such as Lohri, Makar Sankranti, Pongal, Magh Bihu, giving priority to around 30 million healthcare and frontline workers, a health ministry statement said.
 
The decision was taken in a high level meeting chaired by Prime Minister Narendra Modi to review the status of Covid-19 in the country along with the preparedness of the states and union territories for Covid vaccination on Saturday.
 
Indian drug regulator has granted the emergency use authorisation or accelerated approval for two vaccines, Serum Institute of India developed Covishield and Bharat Biotech’s Covaxin, which have established safety and immunogenicity.
 
2,360 participants have been trained during national level Training of Trainers which comprised state immunization officers, cold chain officers,  development partners among others.
 
More than 61,000 programme managers, 200,000 vaccinators and 370,000 other vaccination team members have been trained so far as part of trainings at states, districts and block levels.
 
“The vaccination exercise is underpinned by the principles of people’s participation -Jan Bhagidari; utilizing experience of elections - booth strategy and Universal Immunization Program,” the press statement said.
 
Serum Institute has 50 million doses of vaccines packed at its Pune plant and another 50 million doses are ready to be packed. It can now make around 60-70 million doses per month and once a third plant comes online adjacent to its existing site, it can make 100 million doses per month.
 
In a recent meeting with the Health Minister, states have pointed out several glitches they have faced during the dry run.

Chhattisgarh said it faced network issues in tribal belts, while Telangana has said it faced software issues. Jammu and Kashmir has also raised the issue that most parts of states have 2G connection which has made it difficult to use the Co-Win platform, which is driving the vaccination exercise.
 
Health ministry had assured states of resolving these issues ahead of the roll-out.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

Next Story